⚡️ Latanoprostene Bunod Comes Off Patent 💊 Latanoprostene bunod is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprostene… ➡️ Read more: https://lnkd.in/eNhYx7jK 🌐 Register for free focused news service covering the latest developments in relation to pharmaceutical supply: https://lnkd.in/eitNb3gD #pharma #pharmanews #APIupdates #offpatent #data #analysis #investments
